MMEDF - First Modern Dose-Response Study of LSD Co

MMEDF - First Modern Dose-Response Study of LSD Confirms the Critical Role of the Serotonin 2A Receptor

https://psychedelicreview.com/first-modern-do...-receptor/

Keep in mind MMEDF has a 10 year worldwide exclusive rights to all this lab data from Switzerland. Thats more than enough time to develop drugs and partner with a big pharma partner.

This is the report that proves their "off-switch (ketanserin) works. This is big news folks. Not only for LSD experiential treatments, but things we have never been able to control with other medications that well. It is suggested that ketanserin can be used without LSD to turn off things like schizophrenia


Platelet 5-HT(2A) receptors in schizophrenic patients with and without neuroleptic treatment

https://pubmed.ncbi.nlm.nih.gov/10980325/


Successful treatment of intractable visual hallucinations with 5-HT2A antagonist ketanserin

https://casereports.bmj.com/content/2018/bcr-2018-224340


You can thank all of this to the discovery of LSD and the compounds that affect the 5-HT(2A) receptors. Big things ahead... This is the next TSLA in Biotech and Pharmacology. Science cannot be ignored. Huge information.